![Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials - du Bois - 2009 - Cancer - Wiley Online Library Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials - du Bois - 2009 - Cancer - Wiley Online Library](https://acsjournals.onlinelibrary.wiley.com/cms/asset/7acd71f0-ce88-4572-9317-2650c2de5b04/mfig002.jpg)
Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials - du Bois - 2009 - Cancer - Wiley Online Library
![Quality Indicators and Survival Outcome in Stage IIIB-IVB Epithelial Ovarian Cancer Treated at a Single Institution | In Vivo Quality Indicators and Survival Outcome in Stage IIIB-IVB Epithelial Ovarian Cancer Treated at a Single Institution | In Vivo](https://iv.iiarjournals.org/content/invivo/33/5/1521/F3.large.jpg)
Quality Indicators and Survival Outcome in Stage IIIB-IVB Epithelial Ovarian Cancer Treated at a Single Institution | In Vivo
![Hypoxic isolated abdominal perfusion breaks through chemoresistance in recurrent FIGO stage IIIC and IV ovarian cancer Hypoxic isolated abdominal perfusion breaks through chemoresistance in recurrent FIGO stage IIIC and IV ovarian cancer](https://www.spandidos-publications.com/article_images/mco/14/6/mco-14-06-02291-g01.jpg)
Hypoxic isolated abdominal perfusion breaks through chemoresistance in recurrent FIGO stage IIIC and IV ovarian cancer
![Malignant Bowel Obstruction in Ovarian Cancer Recurrence: The Role of Palliative Surgery in a Decision-Making Process Malignant Bowel Obstruction in Ovarian Cancer Recurrence: The Role of Palliative Surgery in a Decision-Making Process](https://article.imrpress.com/journal/CEOG/49/8/10.31083/j.ceog4908173/2709-0094-49-8-173/fig1.jpg)
Malignant Bowel Obstruction in Ovarian Cancer Recurrence: The Role of Palliative Surgery in a Decision-Making Process
![Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancer Treatment (PDQ®)–Health Professional Version - NCI Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancer Treatment (PDQ®)–Health Professional Version - NCI](https://nci-media.cancer.gov/pdq/media/images/618025.jpg)
Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancer Treatment (PDQ®)–Health Professional Version - NCI
![Survival analysis of revised 2013 FIGO staging classification of epithelial ovarian cancer and comparison with previous FIGO staging classification Survival analysis of revised 2013 FIGO staging classification of epithelial ovarian cancer and comparison with previous FIGO staging classification](https://www.ogscience.org/upload//thumbnails/ogs-58-124-i001.jpg)
Survival analysis of revised 2013 FIGO staging classification of epithelial ovarian cancer and comparison with previous FIGO staging classification
![PDF) Should we modify the current FIGO staging system for stage IIIC ovarian cancer? | Hee-Sug Ryu - Academia.edu PDF) Should we modify the current FIGO staging system for stage IIIC ovarian cancer? | Hee-Sug Ryu - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/74335135/mini_magick20211107-6542-9azoez.png?1636323912)
PDF) Should we modify the current FIGO staging system for stage IIIC ovarian cancer? | Hee-Sug Ryu - Academia.edu
![Patients with stage IV epithelial ovarian cancer: understanding the determinants of survival | Journal of Translational Medicine | Full Text Patients with stage IV epithelial ovarian cancer: understanding the determinants of survival | Journal of Translational Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12967-020-02295-y/MediaObjects/12967_2020_2295_Fig1_HTML.png)
Patients with stage IV epithelial ovarian cancer: understanding the determinants of survival | Journal of Translational Medicine | Full Text
![Influence of p53 Isoform Expression on Survival in High-Grade Serous Ovarian Cancers | Scientific Reports Influence of p53 Isoform Expression on Survival in High-Grade Serous Ovarian Cancers | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-019-41706-z/MediaObjects/41598_2019_41706_Fig1_HTML.png)
Influence of p53 Isoform Expression on Survival in High-Grade Serous Ovarian Cancers | Scientific Reports
![IJERPH | Free Full-Text | Comparing Paclitaxel–Carboplatin with Paclitaxel–Cisplatin as the Front-Line Chemotherapy for Patients with FIGO IIIC Serous-Type Tubo-Ovarian Cancer IJERPH | Free Full-Text | Comparing Paclitaxel–Carboplatin with Paclitaxel–Cisplatin as the Front-Line Chemotherapy for Patients with FIGO IIIC Serous-Type Tubo-Ovarian Cancer](https://www.mdpi.com/ijerph/ijerph-17-02213/article_deploy/html/images/ijerph-17-02213-g001-550.jpg)
IJERPH | Free Full-Text | Comparing Paclitaxel–Carboplatin with Paclitaxel–Cisplatin as the Front-Line Chemotherapy for Patients with FIGO IIIC Serous-Type Tubo-Ovarian Cancer
![Table 2 from Improvements to the FIGO staging for ovarian cancer: reconsideration of lymphatic spread and intraoperative tumor rupture | Semantic Scholar Table 2 from Improvements to the FIGO staging for ovarian cancer: reconsideration of lymphatic spread and intraoperative tumor rupture | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9606df0f465c41a87ca1c599295ca608317792c8/3-Table2-1.png)
Table 2 from Improvements to the FIGO staging for ovarian cancer: reconsideration of lymphatic spread and intraoperative tumor rupture | Semantic Scholar
![Prognostic factors of overall survival for patients with FIGO stage IIIc or IVa ovarian cancer treated with neo-adjuvant chemotherapy followed by interval debulking surgery: A multicenter cohort analysis from the FRANCOGYN study Prognostic factors of overall survival for patients with FIGO stage IIIc or IVa ovarian cancer treated with neo-adjuvant chemotherapy followed by interval debulking surgery: A multicenter cohort analysis from the FRANCOGYN study](https://www.ejso.com/cms/asset/f3e2f230-b13a-4aa6-91a7-9dc89ae7bf61/gr2.jpg)
Prognostic factors of overall survival for patients with FIGO stage IIIc or IVa ovarian cancer treated with neo-adjuvant chemotherapy followed by interval debulking surgery: A multicenter cohort analysis from the FRANCOGYN study
![PDF] FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication | Semantic Scholar PDF] FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/4298961a7b50fab41691cb1442f124159effd2fb/2-Table1-1.png)